Three-dose HPV vaccine completion among sexual and gender minority young adults at a Boston community health centerHuman papillomavirusHPVVaccineHPV-related cancersSexual and gender minorityTransgenderBackground: Disparities in human papillomavirus (HPV) vaccination completion have been noted among sexual and...
through 1 month after the 3rd dose (per-protocol population; vaccine n = 7,811; placebo n = 7,785), the vaccine was 100 % effective (95 % CI: 72 to 100) against VIN2-3 or VaIN2-3 associated with HPV16 or HPV18. In the intention-to-treat population (which included 18,174 women...
The HPV vaccine is given as an injection. You will receive 3 doses of the vaccines in the following interval: First dose: at a date you and your doctor choose Second dose: 1-2 months after the first dose Third dose: 3-4 months after the second dose You are strongly recommended to co...
The quadrivalent vaccine is recommended at 0, 2, and 6 months (minimum interval between 1st and 2nd dose is 4 weeks and the second and third dose is 12 weeks). The bivalent vaccine is the schedule as 0, 1, and 6 months. The HPV vaccine can be administered along with HBV and Tdap v...
CHANGSHA, Jan. 9 (Xinhua) -- China administered its first dose of a human papillomavirus (HPV) vaccine for men in its central Hunan Province on Thursday afternoon, according to the provincial center for disease control and prevention.
Baisley K. Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial. Lancet Glob Health. 2022 Oct;10(10):e1473-e...
In early October, the World Health Organization (WHO) prequalified a fourth human papillomavirus (HPV) vaccine, Cecolin, for single-dose use. The shift from a 2-dose HPV vaccine regimen to an alternative, off-label 1-dose injection schedule, recommended by the WHO in 2022, will help ad...
Correlates for Completion of 3-Dose Regimen of HPV Vaccine in Female Members of a Managed Care Organization OBJECTIVE To examine the rate and correlates of completion of the quadrivalent human papillomavirus vaccine (HPV4) 3-dose regimen because nonadherence to t... Chun Chao and Christine V...
This is a very important analysis and one that needs to be followed very carefully. There is no question that HPV vaccination has had an enormously positive impact in reducing the necessary precursor for the development of cervix cancer, and that with a 2-dose approach the vaccine will be eas...
Table 1. Global and regional female HPV vaccine coverage estimates in 2019, based on program performance coverage indicator. First dose (HPV1)Final dose (HPVc) Empty CellN countries with dataCoverage (weighted by population size)N countries with dataCoverage (weighted by population size) Empty Ce...